<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03805230</url>
  </required_header>
  <id_info>
    <org_study_id>SQUEEZE</org_study_id>
    <nct_id>NCT03805230</nct_id>
  </id_info>
  <brief_title>Postoperative Vasopressor Usage: SQUEEZE</brief_title>
  <acronym>SQUEEZE</acronym>
  <official_title>Postoperative Vasopressor Usage : a Prospective International Observational Study (SQUEEZE)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>European Society of Anaesthesiology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>European Society of Anaesthesiology</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A prospective multi-centre international observational study of postoperative vasopressor use
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Prevalence of postoperative vasopressor usage in a none cardiac surgical population.</measure>
    <time_frame>A the primary endpoint is the proportion of patients receiving vasopressor infusions that start between 1 and 24 hours postoperatively</time_frame>
    <description>1. What proportions of patients receive infused vasopressors postoperatively?</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">40000</enrollment>
  <condition>Surgical Procedures, Operative</condition>
  <condition>Vasopressor</condition>
  <arm_group>
    <arm_group_label>Cohort A</arm_group_label>
    <description>all patients admitted to participating hospitals during 7 consecutive days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cohort B</arm_group_label>
    <description>30 sequential patients with a single additional inclusion criterion</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Adult Patients undergoing any non-cardiac surgical procedure.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Undergoing surgery (may be planned or unplanned)

          -  No plans for return home on the day of surgery, for medical reasons

          -  Age â‰¥ 18 on day of surgery

        Exclusion Criteria:

          -  Cardiac surgery

          -  Obstetric surgery

          -  Transplant surgery

          -  Receiving long-term infusions of vasoactive drugs, such as epoprostenol

          -  Mechanical circulatory support: ventricular assist device, intra-aortic balloon pump,
             artificial heart or similar

          -  Already been enrolled in Squeeze

        For Cohort B - One additional inclusion criterion:

          -  Receiving infusion of vasopressors that continues after the patient has left the
             operating room.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ib Jammer, Dr</last_name>
    <role>Study Chair</role>
    <affiliation>Haukeland University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ben Creagh-Brown</last_name>
    <role>Study Chair</role>
    <affiliation>Royal Surrey County Hospital NHS Foundation Trust</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sylvia Daamen</last_name>
    <phone>003222109414</phone>
    <email>research@esahq.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Pierre Harlet</last_name>
    <phone>3222105773</phone>
    <email>research@esahq.org</email>
  </overall_contact_backup>
  <link>
    <url>http://www.esahq.org/research/clinical-trial-network/planned-trials/squeeze/</url>
    <description>European Society of Anaesthesiology Clinical Trial Network website</description>
  </link>
  <verification_date>January 2019</verification_date>
  <study_first_submitted>January 14, 2019</study_first_submitted>
  <study_first_submitted_qc>January 14, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">January 15, 2019</study_first_posted>
  <last_update_submitted>January 15, 2019</last_update_submitted>
  <last_update_submitted_qc>January 15, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">January 16, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>anaesthesia</keyword>
  <keyword>Intensive Care</keyword>
  <keyword>vasopressor</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

